Zap70 inhibits Syk-mediated osteoclast function

Journal of Cellular Biochemistry

Volumn 114, Issue 8, 2013, Pages 1871-1878

  Zou, Wei ^a   Croke, Monica ^a   Fukunaga, Tomohiro ^a   Broekelmann, Thomas J ^b   Mecham, Robert P ^b   Teitelbaum, Steven L ^a,b  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CYTOSKELETON; INTEGRIN; OSTEOCLAST FUNCTION; TYROSINE KINASE

Indexed keywords

PROTEIN KINASE SYK; PROTEIN KINASE ZAP 70; PROTEIN SH2; VITRONECTIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL SPREADING; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVITY; ENZYME INHIBITION; FETUS; GENE MUTATION; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION;

ANIMALS; CYTOSKELETON; GENE EXPRESSION REGULATION; INTEGRIN ALPHA5; INTEGRIN BETA3; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, KNOCKOUT; OSTEOCLASTS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-VAV; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 84879150473     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24531     Document Type: Article

References (29)

1. Boyle WJ, Simonet WS, Lacey DL,. 2003. Osteoclast differentiation and activation. Nature 423: 337-342.
2. Brdicka T, Kadlecek TA, Roose JP, Pastuszak AW, Weiss A,. 2005. Intramolecular Regulatory Switch in ZAP-70: Analogy with receptor tyrosine kinases. Mol Cell Biol 25: 4924-4933.
3. Croke M, Ross FP, Korhonen M, Williams DA, Zou W, Teitelbaum SL,. 2011. Rac deletion in osteoclasts causes severe osteopetrosis. J Cell Sci 124: 3811-3821.
4. Faccio R, Teitelbaum SL, Fujikawa K, Chappel J, Zallone A, Tybulewicz VL, Ross FP, Swat W,. 2005. Vav3 regulates osteoclast function and bone mass. Nat Med 11: 284-290.
5. -/- osteoclast phenotype. J Cell Biochem 90: 871-883.
6. Gladue RP, Allen M, Cunningham A, Gardner J, Laquerre AM, Connelly PA, Shaw AS, McNeish J,. 1997. Phenotypic characterization and analysis of allogeneic T cell responses in ZAP-70 dominant negative transgenic mice. Clin Exp Immunol 110: 397-402.
7. -/- mice by the Syk protein tyrosine kinase. Immunity 7: 369-377.
8. Hynes RO,. 2002. Integrins: Bidirectional, allosteric signaling machines. Cell 110: 673-687.
9. Kolanus W, Romeo C, Seed B,. 1993. T cell activation by clustered tyrosine kinases. Cell 74: 171-183.
10. Kong GH, Bu JY, Kurosaki T, Shaw AS, Chan AC,. 1995. Reconstitution of Syk function by the ZAP-70 protein tyrosine kinase. Immunity 2: 485-492.
11. Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL,. 2000. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106: 1481-1488.
12. Latour S, Chow LM, Veillette A,. 1996. Differential intrinsic enzymatic activity of Syk and Zap-70 protein-tyrosine kinases. J Biol Chem 271: 22782-22790.
13. McHugh KP, Hodivala-Dilke K, Zheng MH, Namba N, Lam J, Novack D, Feng X, Ross FP, Hynes RO, Teitelbaum SL,. 2000. Mice lacking b3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest 105: 433-440.
14. Noraz N, Schwarz K, Steinberg M, Dardalhon V, Rebouissou C, Hipskind R, Friedrich W, Yssel H, Bacon K, Taylor N,. 2000. Alternative antigen receptor (TCR) signaling in T cells derived from ZAP-70-deficient patients expressing high levels of Syk. J Biol Chem 275: 15832-15838.
15. Palacios EH, Weiss A,., 2007. Distinct roles for Syk and ZAP-70 during early thymocyte development. J Exp Med 204: 1703-1715.
16. Qian D, Mollenauer MN, Weiss A,. 1996. Dominant-negative zeta-associated protein 70 inhibits T cell antigen receptor signaling. J Exp Med 183: 611-620.
17. Reeve JL, Zou W, Liu Y, Maltzman JS, Ross FP, Teitelbaum SL,. 2009. SLP-76 couples Syk to the osteoclast cytoskeleton. J Immunol 183: 1804-1812.
18. Saltel F, Chabadel A, Bonnelye E, Jurdic P,. 2008. Actin cytoskeletal organisation in osteoclasts: A model to decipher transmigration and matrix degradation. Eur J Cell Biol 87: 459-468.
19. Soriano P, Montgomery C, Geske R, Bradley A,. 1991. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64: 693-702.
20. Takata M, Sabe H, Hata A, Inazu T, Homma Y, Nukada T, Yamamura H, Kurosaki T,. 1994. Tyrosine kinases Lyn and Syk regulate B cell receptor-coupled Ca2+ mobilization through distinct pathways. EMBO J 13: 1341-1349.
21. Takeshita S, Kaji K, Kudo A,. 2000. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J Bone Miner Res 15: 1477-1488.
22. Teitelbaum SL,. 2007. Osteoclasts: What do they do and how do they do it? Am J Pathol 170: 427-435.
23. Teitelbaum SL,. 2000. Bone resorption by osteoclasts. Science 289: 1504-1508.
24. Turner M, Mee PJ, Costello PS, Williams O, Price AA, Duddy LP, Furlong MT, Geahlen RL, Tybulewicz VL,. 1995. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature 378: 298-302.
25. Vaananen HK, Zhao H, Mulari M, Halleen JM,. 2000. The cell biology of osteoclast function. J Cell Sci 113: 377-381.
26. van Oers NS, Weiss A,. 1995. The Syk/ZAP-70 protein tyrosine kinase connection to antigen receptor signalling processes. Semin Immunol 7: 227-236.
27. Zou W, Reeve JL, Zhao H, Ross FP, Teitelbaum SL,. 2009. Syk tyrosine 317 negatively regulates osteoclast function via the ubiquitin-protein isopeptide ligase activity of Cbl. J Biol Chem 284: 18833-18839.
28. Zou W, Reeve JL, Liu Y, Teitelbaum SL, Ross FP,. 2008. DAP12 couples c-Fms activation to the osteoclast cytoskeleton by recruitment of Syk. Mol Cell 31: 422-431.
29. Zou W, Kitaura H, Reeve J, Long F, Tybulewicz VLJ, Shattil SJ, Ginsberg MH, Ross FP, Teitelbaum SL,. 2007. Syk, c-Src, the avb3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption. J Cell Biol 176: 877-888.